Login

James P. Scriven, CEO of IDB Invest, explores Latin American finance and investment strategies with the International Finance Corporation. 00:10:00

Share On Facebook Share On Twitter

James P. Scriven, CEO of IDB Invest

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Steadfast Growth and Resilience: Nordea's 2023 Recap | Frank Vang-Jensen, CEO, Nordea .
00:00:00
Carl Syubbings, CEO, Benitec Biopharma Ltd
00:10:00
Black Mountain Energy Unlocking Untapped Gas Power in the Canning Basin | Rhett Bennett, CEO, Black Mountain Energy Ltd.
00:00:00
Dedicare - ABGSC Investor Days 8 mars 2022 - Krister Widstrom, CEO, Dedicare AB (publ)
00:10:00
"Empowering Education Financing: Insights from Ferdinand Wollenberg of the European Investment Fund | Ferdinand Wollenberg - Program Manager, European Investment Fund"
00:10:00
The Impact of Private Equity and Venture Capital on European Growth and Employment | Jim Strang, CHAIRMAN, Hg Capital Trust plc.
00:10:00
Future of Banking: A Conversation with Richard Quest | Piyush Gupta , CEO,  DBS Bank .
00:10:00
Charles Kesler on Obama and the Evolution of American Liberalism|Charles Thomas Kessler
00:10:00
Piyush Gupta's Vision for DBS and Southeast Asia's Future | Piyush Gupta, CEO, DBS Group.
00:10:00
M1's Long-Term Investing Approach vs. Robinhood's Trading Model Amidst Market Volatility
00:10:00
Financial Planning for Medical Professionals | Tristan Crook, CERTIFIED FINANCIAL PLANNER of 308 Financial
00:10:00
Supporting Mental Health in Mining: High-Tech Drilling's Commitment

© 2017 - Neuhu+